As of 2024-12-15, the Fair Value of Ascelia Pharma AB (ACE.ST) is -9.23 SEK. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 21.40 SEK, the upside of Ascelia Pharma AB is -143.12%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -39.91 | -98.70 | -125.90 | -131.22 | -109.29 | -101.00 |
| YoY growth | -7.46% | -147.33% | -27.57% | -4.22% | 16.72% | -33.97% |
| Market Cap (mil) | 722.41 |
| P/E | |
| Forward P/E |
| EPS | -1.85 |
| Avg earnings growth rate | -33.97% |
| TTM earnings | -62.30 |